Company / R&D Expense
Xtant Medical Holdings, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.4M
FY2025
5-year range
$657.0K / $2.4M
FY2021-FY2025
Trend
+78.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 4 consecutive years, from $657,000 in FY2021 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +20.7%.
Improved from $915,000 to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +40.0%
- 5-Year CAGR
- +20.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Xtant Medical Holdings, Inc.'s r&d expense has grown for 4 consecutive years.
- 5-year CAGR of +20.7%, indicating consistent growth.
- In FY2025, r&d expense increased 78.5% year-over-year.
- Peak r&d expense was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4M | +78.5% |
| FY2024 | $1.3M | +46.0% |
| FY2023 | $915.0K | +5.2% |
| FY2022 | $870.0K | +32.4% |
| FY2021 | $657.0K | -29.5% |
| FY2020 | $932.0K | -45.2% |
| FY2019 | $1.7M | -30.3% |
| FY2018 | $2.4M | -28.4% |
| FY2017 | $3.4M | +33.9% |
| FY2016 | $2.5M | +76.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026